Current Perspectives of Anticoagulation in Patients With COVID-19

被引：17
|
作者：
Gavioli, Elizabeth M. [1 ]
Sikorska, Gabriela [1 ]
Man, Ammy [1 ]
Rana, Jay [1 ]
Vider, Etty [1 ,2 ]
机构：
[1] Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Div Pharm, Brooklyn, NY USA
[2] Brookdale Hosp, Med Ctr, Div Pharm, Brooklyn, NY USA
来源：
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 2020年 / 76卷 / 02期
关键词：
SARS-CoV-2; COVID-19; thromboembolism; anticoagulation; MANAGEMENT; DISEASE;
D O I：
10.1097/FJC.0000000000000861
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thromboembolism and myocardial injury is common in patients with COVID-19. Low-molecular-weight heparin appears to be associated with a good prognosis in patients with COVID-19 and has the ability to reduce coagulation and inflammation markers. Hospitalized patients with COVID-19 should be placed on thromboprophylaxis with the option of full therapeutic anticoagulation or tissue plasminogen activator in high-risk or mechanically ventilated patients. Thromboprophylaxis should also be considered at hospital discharge for high-risk patients. Clinical judgment should be used to evaluate the bleeding and safety risk of anticoagulation in patients with COVID-19 without confirmed data.
引用
收藏
页码：146 / 150
页数：5
相关论文
共 50 条
  • [21] COVID-19 and bronchial asthma: current perspectives
    Hojo, Masayuki
    Terada-Hirashima, Junko
    Sugiyama, Haruhito
    GLOBAL HEALTH & MEDICINE, 2021, 3 (02): : 67 - 72
  • [22] COVID-19 Vaccines: Current and Future Perspectives
    Soraci, Luca
    Lattanzio, Fabrizia
    Soraci, Giulia
    Gambuzza, Maria Elsa
    Pulvirenti, Claudio
    Cozza, Annalisa
    Corsonello, Andrea
    Luciani, Filippo
    Rezza, Giovanni
    VACCINES, 2022, 10 (04)
  • [23] COVID-19: Current Challenges and Future Perspectives
    Leggat, Peter A.
    Frean, John
    Blumberg, Lucille
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (02)
  • [24] Anticoagulation is the answer in treating noncritical COVID-19 patients
    Kabir, Azad A.
    OPEN MEDICINE, 2021, 16 (01): : 1486 - 1492
  • [25] Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID-19
    Dobesh, Paul P.
    Trujillo, Toby C.
    PHARMACOTHERAPY, 2020, 40 (11): : 1130 - 1151
  • [26] Therapeutic Anticoagulation with Heparin in Patients with Covid-19 Reply
    Zarychanski, Ryan
    Lawler, Patrick R.
    Goligher, Ewan
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21): : 2014 - 2014
  • [27] The role of anticoagulation therapy in management of Covid-19 patients
    Rajagopalan, P.
    Ahmed, K.
    RESPIROLOGY, 2022, 27 : 213 - 213
  • [28] Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients
    Warrior, Surbhi
    Behrens, Elizabeth
    Thomas, Joshua
    Rajakumar, Priya
    Gezer, Sefer
    Venugopal, Parameswaran
    Jain, Shivi
    BLOOD, 2020, 136
  • [29] THE ROLE OF ANTICOAGULATION THERAPY IN MANAGEMENT OF COVID-19 PATIENTS
    Shahid, S.
    Elsharkawy, A.
    Dethabrew, A.
    Gani, A.
    Elgizouli, M.
    Islam, R.
    Zahid, M. A.
    Taylor, O.
    Gupta, S.
    Kashem, M.
    Newman, O.
    Kashem, M.
    Kuckreja, S.
    Naik, S.
    Ekeowa, U.
    Khan, K.
    Anwar, M. S.
    THORAX, 2021, 76 : A60 - A60
  • [30] Coagulation and anticoagulation in COVID-19
    Hadid, Tarik
    Kafri, Zyad
    Al-Katib, Ayad
    BLOOD REVIEWS, 2021, 47
12345